Loading...
Loading...
BMO Capital Markets reiterated its Outperform rating on Danaher
DHR and raised the price target from $66.00 to $69.00.
BMO Capital Markets commented, "Danaher reported GAAP EPS of $0.89, including a $0.02 gain from mark-tomarket currency swaps. Adjusting for this benefit, adjusted EPS was $0.87. The earnings results were driven by better-than-expect revenue in Test & Measurement (3.3% better), Environmental (1.9% better), Life Sciences & Diagnostics (1.0% better), and Industrial Technologies (3.7% better), and better-than-expected operating margins in Environmental (144 bp better) and Life Sciences & Diagnostics (174 bp better)."
Danaher closed at $61.00 on Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in